Healthcare >> CEO Interviews >> March 29, 2004
Ian Page joined Dechras principal trading subsidiary NVS at its formation in 1989 and was appointed Managing Director in 1998. He joined the Main Board in 1997 and became Chief Executive in November 2001. Ian has played a key role in the development of the Groups growth strategy. Prior to joining the Company, he gained extensive knowledge and experience through various positions he held within the pharmaceutical and medical arena. Profile
TWST: Please start with a brief introduction to the Company - a brief historical sketch and where it's placed right now.
Mr. Page: I would describe us as an emerging pharmaceutical